-
GE Healthcare cuts 31,000 employees as a whole, layoffs may continue in 2021
Time of Update: 2021-02-24
2021, or continue to lay off According to GE's annual report, it has been carrying out a number of cost reduction and restructuring efforts that may adversely affect operations, employee retention, performance and reputation, and may not achieve the expected benefits.
-
Coxing Zhongwei's new crown inactivated vaccine has been approved for sale in China
Time of Update: 2021-02-24
11 January, the Indonesian Drug and Food Administration announced that it had granted emergency approval for the vaccine.
-
The State Drug Administration identified the second batch of 72 key laboratories, such as in-body diagnostic reagent quality research and evaluation
Time of Update: 2021-02-24
February 2021, the State Drug Administration identified and announced the second batch of 72 key laboratories, such as in-body diagnostic reagent quality research and evaluation.
, improving the drug regulatory authority's ability to respond to major public health emergencies has become an important consideration in the comprehensive evaluation.
-
Domestic PD-1 was approved for new adaptive diseases major pharmaceutical companies must compete for the track
Time of Update: 2021-02-24
present, in addition to Junshi Bio, Hengrui's Karelli Zhu single anti-nasopharyngeal cancer after-line treatment and first-line treatment of new adaptive disorders have also been declared on the market, is in the review and approval stage.
-
The application for listing of Trotsip for the injection of Baishi Meishiguibao was accepted for priority review
Time of Update: 2021-02-24
According to Insight Global's new drug library, Luspatercept was first approved by the U.S. FDA in November 2019 for the treatment of adult β-thalassemia patients requiring regular infusion of red blood cells (RBCs), an adaptive disorder that is currently listed in Canada and the European Union.
-
External JAK inhibitors for the treatment of eczema Incyte use priority vouchers to submit applications for new drugs
Time of Update: 2021-02-24
trial results showed that in two Phase 3 clinical trials, patients treated with different doses of reedcotinie cream were significantly better than the control group after 8 weeks of treatment.
Retrieved February 19, 2021, from [2] Ruxolitinib Cream: Phase 3 Data in Atopic Dermatitis.
-
The official briefing is coming! The State Drug Administration disclosed the latest progress in the development of the new crown vaccine
Time of Update: 2021-02-24
Pharma Network February 19 - February 19, the Supreme People's Procuratorate, the State Administration of Market Supervision and Administration and the State Drug Administration, jointly issued 15 imp
-
Pharmaceutical companies' China revenue, Top7 announced (with list)
Time of Update: 2021-02-24
According to The Rubik's Cube, seven foreign pharmaceutical companies that announced China's performance will achieve a total of $21.4 billion in 2020, of which AstraZeneta continues to rank first in the Chinese market for multinational pharmaceutical companies with nearly $5.4 billion in Chinese revenue, with Merca East and Roche in second and third place respectively.
-
The study revealed the exact cause of death of a python in ancient Egypt 3,600 years ago
Time of Update: 2021-02-24
CAIRO, Feb. 17 (Xinhua Wu Dani Marwa Yahya) Egyptian archaeologists and medical experts published a study on the 17th showed that about 3,600 years ago, the ancient Egyptian 17th Dynasty python Segenenla should have been killed in the battle with the Hexos, whose head wounds were cleverly hidden by mummy makers.
-
State Drug Administration: The six-flavored yellow preparation instructions for a unified revision
Time of Update: 2021-02-24
the announcement stressed that the provincial drug supervision and administration departments should urge the drug market license holders of the above-mentioned drugs in the administrative area to do a good job in accordance with the requirements of the corresponding manual revision and labeling, manual replacement work, the violation of the law and strict investigation and punishment.
-
Volunteers "testing drugs on their es"? The United States has approved human trials of the new coronavirus
Time of Update: 2021-02-24
At that time, 90 adult volunteers between the ages of 18 and 30 will be exposed to the new coronavirus in a safe and controlled environment to help researchers understand how the human body responds to the virus, how it spreads, and the minimum number of viruses needed to cause infection.
-
Officially implemented from March 1st! There are new changes in the list of medical insurance drugs in Hebei Province
Time of Update: 2021-02-24
At the same time, Class A drugs, which do not set an individual out-of-payment ratio, shall be paid by the Basic Medical Insurance Fund in accordance with the provisions; of class B drugs (excluding negotiated drugs during the agreement period) the proportion of individual out-of-payment was uniformly determined at 5% in the province.
-
Price reduction of 80%, such medical devices only 3.6 yuan
Time of Update: 2021-02-24
Pharmaceutical Network February 18, an average drop of 80% recently, according to the Hunan Provincial Health Insurance Bureau, from February 10, Hunan Province officially implemented the new coronavirus nucleic acid testing related medical supplies centralized procurement results.
-
The limit is approaching 44 large varieties from August 1st to transfer a local health insurance
Time of Update: 2021-02-24
Medical network February 20th, the big limit approaching, local medical insurance transfer work continues, 44 large varieties from August 1st transferred out of a local medical insurance catalog 44 la
-
Six-flavored yellow pill modification instruction manual Adverse reactions increased by 13 items
Time of Update: 2021-02-24
It is cold and greasy, can not eat a lot of people Zhu Xinyi told Yangzi Evening News reporter, taking six-flavored yellow preparations, the most common adverse reaction is the symptoms of the digestive tract, mainly because the six-flavored yellow pills belong to the cold medicine, at the same time it is a complementary drug, so it is greasy.
-
Maximum drop of 96.24%! 113 injection belt volume procurement selected
Time of Update: 2021-02-24
Pharmaceutical Network February 19th, Wuhan Pharmaceuticals Joint Procurement Office announced the first batch of drugs in Hubei Province centralized band procurement results, 29 injection varieties all successfully purchased, a total of 113 drugs selected.
-
Anticipate the future | The 13 clinically urgent needs of new drugs from abroad are expected to be approved for sale in China in 2021
Time of Update: 2021-02-24
According to public information, in China, companies such as Yan Jian and Janssen have earlier jointly submitted applications for the listing of new drugs for fumarate methamphetate intestinal capsules, and have been given priority review by CDE for treatment of adult patients with multiple sclerosis: including clinical isolation syndrome, relapse remission, and active secondary progression.
-
45 over 100 million varieties dominate the Chinese medicine market! 5 exclusive injections killed...
Time of Update: 2021-02-24
Pharmaceutical Network February 20, before the Spring Festival, "on the promotion of drug centralized band procurement normalized institutionalization of the views" issued, which will clearly explore
-
New technology pulls out 'silent killer' in tumor stem cells
Time of Update: 2021-02-24
Surprisingly, these tumor stem cells are usually in a resting state, with low telomerase activity and the ability to maintain relatively short telomere lengths due to their non-proliferation.
-
The six-flavored yellow instruction manual was changed to affect more than 500 pharmaceutical companies
Time of Update: 2021-02-24
Six-flavored yellow preparation over-the-counter prescription drug instructions revised requirements: First, the "adverse reactions" item should include: monitoring data show that hexa-yellow preparations have diarrhea, abdominal pain, bloating, nausea, vomiting, gastrointestinal discomfort, loss of appetite, constipation, itching, rash, headache, palpitations, allergies and other adverse reactions reported.
